ASRT - assertiotx.com Qarzning balans kapitallashuviga nisbati
Assertio Holdings, Inc. (ASRT) kompaniyasidagi samarali boshqaruv xarajatlarni optimallashtirdi va daromadli brendlarni sotib olishga e'tibor qaratdi. Ushbu qarz va kapital tuzilmasi sxemasi moliyaviy barqarorlikni namoyish etadi, bunda joriy parametr 0.51 ga tengdir. Ushbu strategiya nish dori vositalarini sotib olish orqali generik bosimni yumshatishga yordam beradi, garchi og'riq qoldiruvchi dori vositalari uchun patent muddatining tugashi biznesning himoya to'siqlarini izchil ravishda zaiflashtirayotgan bo'lsa-da.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ASRT_-_Assertio-Holdings-Inc._-_Debt-to-Net-Assets-Ratio "Assertio Holdings, Inc. - ASRT Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 27.06.2026) | 👁️GURU.Markets👁️")
assertiotx.com (ASRT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Assertio|ASRT - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar ASRT|ASRT - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Assertio
Kompaniyaning fundamental tahlili:Assertio Therapeutics - ASRT
Assertio Holdings, Inc. (ASRT) kompaniyasining portfelni kengaytirish strategiyasi kompaniyaning umumiy qarzdorligining uning ekvity kapitaliga nisbatida aks etgan. Ushbu ko'rsatkich umumiy majburiyatlarni ekvity bilan solishtirish orqali moliyaviy avtonomiya darajasini baholaydi. Hisob-kitob barcha qarz mablag'larini sof ekvity qiymatiga bo'lishga asoslangan. Past qiymatlar defoltga chidamlilikni tasdiqlaydi, ammo investitsiyalarga konservativ yondashuvdan dalolat berishi mumkin. Investor uchun xavfsizlik va biznesning o'sish sur'ati o'rtasida muvozanatni saqlash juda muhimdir.
Assertio Holdings, Inc. kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|VKTX (Viking Therapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar SUPN|CPRX (Catalyst Pharmaceuticals, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar DNLI (Denali)|Qarzning balans kapitallashuviga nisbati HRMY|Sof aktivlarga qarzlar Biohaven Corp BHVN|AMLX (Amylyx Pharmaceuticals) - Balans kapitallashuviga qarzlar|TRVI: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Praxis Precision Medicines, Inc. PRAX|Qarzning sof aktivlarga nisbati Anavex|CeriBell Corp (CBLL) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati prothena.com|ALEC (Alector, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ANNX (annexonbio.com)|OMER: Qarzning balans kapitallashuviga nisbati|NGNE - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati AC Immune Corp (ACIU)|VYGR - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Neumora Therapeutics NMRA|SCLX (scilexholding.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati TVGN (Tevogen Bio)|Balans qiymatiga qarzlar ACOG|Qarzning balans kapitallashuviga nisbati Cognition Therapeutics (CGTX)|Qarzning balans kapitallashuviga nisbati Inhibikase Pharma (IKT)|SAVA - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Coya Therapeutics Inc COYA|Balans kapitallashuviga qarzlar VTGN (VistaGen Therapeutics Inc)|OVID: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Acumen Pharma|CervoMed Corporation (CRVO) - Qarzning balans qiymatiga nisbati|Alterity Therapeutics Ltd. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati CLNN|PEPG (PepGen Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Jupiter Neurosciences, Inc. JUNS|Qarzning balans qiymatiga nisbati Relmada|Qarzning sof aktivlarga nisbati Annovis Bio Corporation ANVS|Balans kapitallashuviga qarzlar GRCE (Grace Tx)|AIFF: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati anewmeds.com|NeuroSense Therapeutics Ltd. (NRSN) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar RVPH|Qarzning balans qiymatiga nisbati MetaVia, Inc. (MTVA)|NRXS (NeurAxis, Inc.) - Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar heliusmedical.com (HSDT)|Balans kapitallashuviga qarzlar PASG (Passage Bio)|Neuphoria Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati NERV (Minerva Neurosciences Corp)|ATHA: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Addex Therapeutics ADXN|Qarzning sof aktivlarga nisbati Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati PTIX|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics KTTA|Qarzning balans qiymatiga nisbati cortigent.com (CRGT)|ATXI: Balans kapitallashuviga qarzlar|BCLI - Balans qiymatiga qarzlar|Cara Therapeutics - Qarzning balans qiymatiga nisbati|CHRO: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati eliemtx.com ELYM|ITCI (Intra-Cellular Therapies, Inc.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati LBPH (Longboard Pharmaceuticals)|Balans qiymatiga qarzlar marinuspharma.com|Balans kapitallashuviga qarzlar NKGN|Balans kapitallashuviga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|Qarzning balans kapitallashuviga nisbati SAGE|Synaptogenix, Inc - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati TRVN (Trevena, Inc.)|VIGL - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar WENA|CERE (Cerevel Therapeutics Inc) - Balans qiymatiga qarzlar